These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33459708)

  • 1. A Single-Chain Variable Fragment Antibody Inhibits Aggregation of Phosphorylated Tau and Ameliorates Tau Toxicity in vitro and in vivo.
    Li S; Yi Y; Cui K; Zhang Y; Chen Y; Han D; Sun L; Zhang X; Chen F; Zhang Y; Yang Y
    J Alzheimers Dis; 2021; 79(4):1613-1629. PubMed ID: 33459708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models.
    Krishnaswamy S; Huang HW; Marchal IS; Ryoo HD; Sigurdsson EM
    Neurobiol Dis; 2020 Apr; 137():104770. PubMed ID: 31982516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.
    Abskharon R; Seidler PM; Sawaya MR; Cascio D; Yang TP; Philipp S; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Felgner PL; Nakajima R; Glabe CG; Eisenberg DS
    J Biol Chem; 2020 Jul; 295(31):10662-10676. PubMed ID: 32493775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.
    Zhang S; Zhu Y; Lu J; Liu Z; Lobato AG; Zeng W; Liu J; Qiang J; Zeng S; Zhang Y; Liu C; Liu J; He Z; Zhai RG; Li D
    Elife; 2022 Sep; 11():. PubMed ID: 36048712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.
    Zhang X; Huai Y; Cai J; Song C; Zhang Y
    Int Immunopharmacol; 2019 Feb; 67():176-185. PubMed ID: 30553911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.
    Esteves-Villanueva JO; Trzeciakiewicz H; Loeffler DA; Martić S
    Biochemistry; 2015 Jan; 54(2):293-302. PubMed ID: 25545358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
    van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
    Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single chain variable fragment against aβ expressed in baculovirus inhibits abeta fibril elongation and promotes its disaggregation.
    Zhang Y; Yang HQ; Fang F; Song LL; Jiao YY; Wang H; Peng XL; Zheng YP; Wang J; He JS; Hung T
    PLoS One; 2015; 10(4):e0124736. PubMed ID: 25919299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of serine 305 in tau inhibits aggregation.
    Strang KH; Sorrentino ZA; Riffe CJ; Gorion KM; Vijayaraghavan N; Golde TE; Giasson BI
    Neurosci Lett; 2019 Jan; 692():187-192. PubMed ID: 30423399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation.
    Huang Y; Wu Z; Cao Y; Lang M; Lu B; Zhou B
    Cell Rep; 2014 Aug; 8(3):831-42. PubMed ID: 25066125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes.
    Goodwin MS; Sinyavskaya O; Burg F; O'Neal V; Ceballos-Diaz C; Cruz PE; Lewis J; Giasson BI; Davies P; Golde TE; Levites Y
    Mol Ther; 2021 Feb; 29(2):859-872. PubMed ID: 33128896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy.
    Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory study.
    Klaver AC; Coffey MP; Bennett DA; Loeffler DA
    Transl Neurodegener; 2017; 6():32. PubMed ID: 29204273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.